台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    23.90
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    107
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/16 ~ 2024/04/30     後一日»

券商獲利排行 - 2024/04/16 ~ 2024/04/30

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.39%76.71.175.6-224322724.223.924.223.9
  1.59%27.5027.5-7017124.324.324.323.9
  1.02%22.313.68.7-27649124.12424.223.9
  1.32%19.9019.9-6206224.2024.223.9
  1.62%7.907.9-2002024.3024.323.9
  0.55%7.925.8-23365924.124.124.223.9
  1.45%7.80.27.6-1932224.324.224.323.9
  0.80%7.77.30.4-1394024.224.124.323.9
  1.48%7.207.2-2002024.3024.323.9
  1.41%6.80.86.1-1552024.324.224.323.9
  1.23%6.80.56.3-2212324.223.724.223.9
  0.13%6.7-11.518.1-9910820724.124.224.123.9
  0.91%6.30.36-2622924.12424.123.9
  1.24%606-1902024.224.224.223.9
  1.24%606-2002024.2024.223.9
  1.22%5.9-0.16-1912024.224.424.223.9
  1.15%5.905.9-2102124.2024.223.9
  1.40%5.44.90.4-2141623.923.824.123.9
  0.72%4.70.24.5-2152724.124.124.123.9
  0.49%4.104.1-350352402423.9
  1.65%404-1001024.3024.323.9
  0.72%3.803.8-2202224.1024.123.9
  0.79%3.80.23.6-1822024.12424.123.9
  0.53%3.303.3-260262402423.9
  0.41%3.203.23333023.823.8023.9
  2.29%2.82.800552423.824.323.9
  1.56%2.702.7-70724.3024.323.9
  1.08%2.62.10.5410523.923.824.223.9
  0.51%2.62.7-0.10212024.12424.123.9
  1.04%2.502.5-1001024.2024.223.9
  1.29%2.502.5-80824.2024.223.9
  1.04%2.52.500101024.12424.323.9
  1.65%2.402.4-60624.3024.323.9
  0.81%2.402.4-1201224.1024.123.9
  0.89%2.402.4-1101124.1024.123.9
  1.36%2.30.71.6-52724.223.924.223.9
  1.85%2.302.3-50524.4024.423.9
  0.81%2.202.2-1101124.1024.123.9
  0.67%2.1-0.12.2-1031324.124.224.123.9
  1.65%202-50524.3024.323.9
  1.03%20.61.4-44824.224.124.323.9
  1.34%202-60624.2024.223.9
  1.95%1.901.9-40424.4024.423.9
  1.65%1.601.6-40424.3024.323.9
  0.81%1.601.6-80824.1024.123.9
  0.80%1.601.6-80824.124.424.123.9
  0.62%1.501.5-1001024.1024.123.9
  1.23%1.5-0.11.6-41524.324.424.323.9
  1.25%1.51.5005524.123.924.223.9
  1.44%1.401.4-40424.3024.323.9

券商虧損排行 - 2024/04/16 ~ 2024/04/30

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.24%-62.20-62.2208208024.224.2023.9
  -1.18%-22-0.2-21.767771024.224.224.223.9
  -1.68%-17.60-17.54243124.324.324.323.9
  -0.96%-14.7-4.9-9.729633424.224.224.123.9
  -1.11%-11.60.5-12.14043324.224.224.423.9
  -0.94%-10.50-10.54646024.124.1023.9
  -1.50%-10.20-10.22828024.324.3023.9
  -1.31%-9.6-0.8-8.82430624.224.324.123.9
  -0.98%-9.1-5.5-3.67383024.324.424.223.9
  -1.33%-9.10-9.12728024.224.224.123.9
  -2.09%-7.60-7.61515024.424.4023.9
  -1.09%-7.40-7.42828024.224.2023.9
  -1.03%-70-72828024.124.1023.9
  -1.65%-5.60-5.61414024.324.3023.9
  -1.78%-5.5-5.2-0.4-310132424.323.823.9
  -1.65%-5.20-5.21313024.324.3023.9
  -0.43%-4.6-0.3-4.33745824242423.9
  -1.27%-4.30-4.31414024.224.2023.9
  -1.36%-4.3-0.1-4.21213124.324.324.223.9
  -1.30%-4.1-0.5-3.61013324.224.324.123.9
  -1.18%-40-41414024.224.2023.9
  -1.10%-3.90-3.9-1501523.6023.623.9
  -0.25%-3.8-4.81-5596424.124.224.123.9
  -1.54%-3.80-3.81010024.324.3023.9
  -1.17%-3.4-0.4-31012224.224.22423.9
  -1.64%-3.2-0.1-3.278124.324.424.323.9
  -1.85%-3.20-3.277024.424.4023.9
  -0.71%-3.1-1-2.16181224.224.324.223.9
  -0.94%-3-0.3-2.7913424.224.224.123.9
  -2.25%-2.80-2.855024.524.5023.9
  -0.59%-2.6-0.8-1.814184242423.823.9
  -1.75%-2.60-2.666024.324.3023.9
  -1.44%-2.40-2.477024.324.224.523.9
  -0.58%-2.30-2.3161602424023.9
  -1.09%-2.1-1.2-0.938524.124.22423.9
  -1.04%-20-288024.224.2023.9
  -1.65%-20-255024.324.3023.9
  -1.38%-2-0.8-1.246224.124.223.823.9
  -1.61%-20-255024.324.3023.9
  -1.31%-1.90-1.956024.224.224.123.9
  -1.52%-1.90-1.955024.324.3023.9
  -1.52%-1.9-0.8-125324.324.424.123.9
  -1.06%-1.80-1.877024.224.2023.9
  -0.49%-1.8-0.8-15151024.124.12423.9
  -1.80%-1.80-1.844024.324.3023.9
  -1.21%-1.80-1.856024.224.224.223.9
  -1.44%-1.80-1.855024.324.3023.9
  -1.44%-1.70-1.755024.224.2023.9
  -0.83%-1.60.2-1.868224.224.224.323.9
  -0.79%-1.50-1.588024.124.1023.9
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章